Journal of Surgery Concepts & Practice >
Impact of polyploid hepatocyte status on liver fibrosis, liver cirrhosis, and tumor recurrence
Received date: 2024-12-27
Online published: 2026-06-23
Human somatic cells are inherently diploid, and an increase in chromosomal content results in polyploidy. The liver is one of the few human organs that is uniquely enriched in polyploid hepatocytes. Hepatocyte polyploidization participates in liver development and the progression of diverse hepatic diseases. This review systematically integrated recent advances in hepatocyte ploidy research by outlining the principal modes of ploidy transition, delineating distinct ploidy states, and emphasizing the mechanistic differences between binucleated and mononucleated polyploid hepatocytes. We further concentrated on mononucleated polyploid hepatocytes, examining the pathological conditions that underpin their emergence and linking these changes to liver cirrhosis and hepatocellular carcinoma (HCC) recurrence. Across chronic liver diseases that predispose to liver cirrhosis, aberrant expansion of mononucleated polyploid hepatocytes not only accelerated progression liver fibrosis and cirrhosis, but also showed a strong association with clinical outcomes in patients with HCC. Elucidating the regulatory mechanisms that govern mononucleated polyploidization will provide a conceptual foundation for improving the fibrotic and cirrhotic microenvironment and for informing therapeutic strategies aimed at preventing HCC recurrence.
Key words： Polyploidy; Hepatocyte; Ploidy; Liver fibrosis; Hepatocellular carcinoma
LUO Xinyi , LU Yiquan , ZHANG Yifan , WANG Nan , HAO Fengjie , WANG Junqing . Impact of polyploid hepatocyte status on liver fibrosis, liver cirrhosis, and tumor recurrence[J]. Journal of Surgery Concepts & Practice, 2026 , 31(02) : 169 -174 . DOI: 10.16139/j.1007-9610.2026.02.12
| [1] | KIM J Y, CHOI H, KIM H J, et al. Polyploidization of hepatocytes: insights into the pathogenesis of liver diseases[J]. Biomol Ther(Seoul), 2022, 30(5):391-398. |
| [2] | GENTRIC G, CELTON-MORIZUR S, DESDOUETS C. Polyploidy and liver proliferation[J]. Clin Res Hepatol Gastroenterol, 2012, 36(1):29-34. |
| [3] | BAILEY E C, KOBIELSKI S, PARK J, et al. Polyploidy in tissue repair and regeneration[J]. Cold Spring Harb Perspect Biol, 2021, 13(10):a040881. |
| [4] | WILKINSON P D, DUNCAN A W. Differential roles for diploid and polyploid hepatocytes in acute and chronic liver injury[J]. Semin Liver Dis, 2021,41:42-49. |
| [5] | DONNE R, SAROUL-A?NAMA M, CORDIER P, et al. Polyploidy in liver development, homeostasis and disease[J]. Nat Rev Gastroenterol Hepatol, 2020,17:391-405. |
| [6] | SLADKY V C, EICHIN F, REIBERGER T, et al. Polyploidy control in hepatic health and disease[J]. J Hepatol, 2021, 75(5):1177-1191. |
| [7] | TORMOS A M, TALéNS-VISCONTI R, SASTRE J. Regulation of cytokinesis and its clinical significance[J]. Crit Rev Clin Lab Sci, 2015, 52(4):159-167. |
| [8] | GENTRIC G, DESDOUETS C, CELTON-MORIZUR S. Hepatocytes polyploidization and cell cycle control in liver physiopathology[J]. Int J Hepatol, 2012,2012:282430. |
| [9] | DONNE R, SANGOUARD F, CELTON-MORIZUR S, et al. Hepatocyte polyploidy: driver or gatekeeper of chronic liver diseases[J]. Cancers(Basel), 2021, 13(20):5151. |
| [10] | CELTON-MORIZUR S, MERLEN G, COUTON D, et al. Polyploidy and liver proliferation: central role of insulin signaling[J]. Cell Cycle, 2010, 9(3):460-466. |
| [11] | FANG J, DE BRUIN A, VILLUNGER A, et al. Cellular polyploidy in organ homeostasis and regeneration[J]. Protein Cell, 2023, 14(8):560-578. |
| [12] | DEWHURST M R, OW J R, ZAFER G, et al. Loss of hepatocyte cell division leads to liver inflammation and fibrosis[J]. PLoS Genet, 2020, 16(11):e1009084. |
| [13] | PINZANI M, ROSSELLI M, ZUCKERMANN M. Liver cirrhosis[J]. Best Pract Res Clin Gastroenterol, 2011, 25(2):281-290. |
| [14] | GUILLARD J, UNTEREINER V, GARNOTEL R, et al. Longitudinal study of cirrhosis development in stam and carbon tetrachloride mouse models using fourier transform infrared spectral imaging[J]. Lab Invest, 2023, 103(10):100231. |
| [15] | 袁振刚, 叶胜龙. 肝细胞癌系统治疗策略:现状和前景[J]. 中华肝脏病杂志, 2024, 32(6):565-571. |
| YUAN Z G, YE S L. Systemic therapeutic strategies for hepatocellular carcinoma: current status and prospects[J]. Chin J Hepatol, 2024, 32(6):565-571. | |
| [16] | CABEL T, PASCU C M, GHENEA C S, et al. Exceptional liver transplant indications: unveiling the uncommon landscape[J]. Diagnostics (Basel), 2024, 14(2):226. |
| [17] | MATSUMOTO T, WAKEFIELD L, TARLOW B D, et al. In vivo lineage tracing of polyploid hepatocytes reveals extensive proliferation during liver regeneration[J]. Cell Stem Cell, 2020, 26(1):34-47,e3. |
| [18] | BU W, SUN X, XUE X, et al. Early onset of pathological polyploidization and cellular senescence in hepatocytes lacking RAD51 creates a pro-fibrotic and pro-tumorigenic inflammatory microenvironment[J]. Hepatology, 2025, 81(2):491-508. |
| [19] | GENTRIC G, MAILLET V, PARADIS V, et al. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease[J]. J Clin Invest, 2015, 125(3):981-992. |
| [20] | HSU S H, DUNCAN A W. Pathological polyploidy in liver disease[J]. Hepatology, 2015, 62(3):968-970. |
| [21] | TOYODA H, BREGERIE O, VALLET A, et al. Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis[J]. Gut, 2005, 54(2):297-302. |
| [22] | YIN K, LI X, LUO X, et al. Hepatoprotective effect and potential mechanism of aqueous extract from phyllanthus emblica on carbon-tetrachloride-induced liver fibrosis in rats[J]. Evid Based Complement Alternat Med, 2021,2021:5345821. |
| [23] | ZHANG L, YANG Z, ZHANG S, et al. Polyploidy spectrum correlates with immunophenotype and shapes hepatocellular carcinoma recurrence following liver transplantation[J]. J Inflamm Res, 2022,15:217-233. |
| [24] | WANG J, HUANG X, ZHENG D, et al. PRMT5 determines the pattern of polyploidization and prevents liver from cirrhosis and carcinogenesis[J]. J Genet Genomics, 2023, 50(2):87-98. |
| [25] | ZHANG Y, WANG N, HAO F, et al. Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short-term recurrence of hepatocellular carcinoma post-radical surgery[J]. FASEB J, 2023, 37(11):e23271. |
| [26] | BANGRU S, CHEN J, BAKER N, et al. ESRP2-microRNA-122 axis promotes the postnatal onset of liver polyploidization and maturation[J]. Genes Dev, 2025, 39(5-6):325-347. |
| [27] | DARMASAPUTRA G S, GEERLINGS C C, CHUVA DE SOUSA LOPES S M, et al. Binucleated human hepatocytes arise through late cytokinetic regression during endomitosis M phase[J]. J Cell Biol, 2024, 223(8):e202403020. |
| [28] | MA Y, JONSSON K, ARYAL B, et al. Endoreplication mediates cell size control via mechanochemical signaling from cell wall[J]. Sci Adv, 2022, 8(49):eabq2047. |
| [29] | WANG P, HUANG Z, PENG Y, et al. Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair[J]. Nat Commun, 2022, 13(1):6502. |
| [30] | LINDQVIST A, VAN ZON W, KARLSSON ROSENTHAL C, et al. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression[J]. PLoS Biol, 2007, 5(5):e123. |
| [31] | KREIS N N, LOUWEN F, YUAN J. Less understood issues: p21(Cip1) in mitosis and its therapeutic potential[J]. Oncogene, 2015, 34(14):1758-1767. |
| [32] | CLERBAUX L A, CORDIER P, DESBOEUFS N, et al. Mcl-1 deficiency in murine livers leads to nuclear polyploidisation and mitotic errors: implications for hepatocellular carcinoma[J]. JHEP Rep, 2023, 5(10):100838. |
| [33] | MANOUSAKIS E, MIRALLES C M, ESQUERDA M G, et al. CDKN1A/p21 in breast cancer: part of the problem, or part of the solution?[J]. Int J Mol Sci, 2023, 24(24):17488. |
| [34] | CASTEDO M, PERFETTINI J L, ROUMIER T, et al. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe[J]. Cell Death Differ, 2002, 9(12):1287-1293. |
| [35] | MATSUMOTO T, WAKEFIELD L, PETERS A, et al. Proliferative polyploid cells give rise to tumors via ploidy reduction[J]. Nat Commun, 2021, 12(1):646. |
| [36] | MATSUMOTO T. Implications of polyploidy and ploidy alterations in hepatocytes in liver injuries and cancers[J]. Int J Mol Sci, 2022, 23(16):9409. |
| [37] | WANG Z, ZHANG Y, WANG Y, et al. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF-κB pathway[J]. J Biochem Mol Toxicol, 2023, 37(7):e23338. |
| [38] | DEWIDAR B, MEYER C, DOOLEY S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019[J]. Cells, 2019, 8(11):1419. |
| [39] | FABREGAT I, CABALLERO-DíAZ D. Transforming growth factor-β-induced cell plasticity in liver fibrosis and hepatocarcinogenesis[J]. Front Oncol, 2018,8:357. |
| [40] | FRANGOGIANNIS N G. Transforming growth factor-β in tissue fibrosis[J]. Nat Rev Cardiol, 2022, 19(7):435-455. |
| [41] | GERMANI G, BURROUGHS A K, DHILLON A P. The relationship between liver disease stage and liver fibrosis: a tangled web[J]. Histopathology, 2010, 57(6):773-784. |
| [42] | AHODANTIN J, BOU-NADER M, CORDIER C, et al. Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation[J]. Oncogene, 2019, 38(14):2645-2657. |
| [43] | BOUCHARD M J, SCHNEIDER R J. The enigmatic X gene of hepatitis B virus[J]. J Virol, 2004, 78(23):12725-12734. |
| [44] | SIVASUDHAN E, BLAKE N, LU Z, et al. Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: a comprehensive review[J]. Cells, 2022, 11(4):741. |
| [45] | CHEN Y F, CHONG C L, WU Y C, et al. Doxorubicin activates hepatitis B virus replication by elevation of p21 (Waf1/Cip1) and C/EBPα expression[J]. PLoS One, 2015, 10(6):e0131743. |
| [46] | PARAMOS-DE-CARVALHO D, JACINTO A, SAúDE L. The right time for senescence[J]. Elife, 2021,10:e72449. |
| [47] | ENGELMANN C, TACKE F. The potential role of cellular senescence in non-alcoholic fatty liver disease[J]. Int J Mol Sci, 2022, 23(2):652. |
| [48] | WILSON S R, DUNCAN A W. The ploidy state as a determinant of hepatocyte proliferation[J]. Semin Liver Dis, 2023, 43(4):460-471. |
| [49] | SLADKY V C, KNAPP K, SORATROI C, et al. E2F-family members engage the piddosome to limit hepatocyte ploidy in liver development and regeneration[J]. Dev Cell, 2020, 52(3):335-349,e337. |
| [50] | SLADKY V C, KNAPP K, SZABO T G, et al. PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis[J]. EMBO Rep, 2020, 21(12):e50893. |
| [51] | BOU-NADER M, CARUSO S, DONNE R, et al. Polyploidy spectrum: a new marker in HCC classification[J]. Gut, 2020, 69(2):355-364. |
/
| 〈 |
|
〉 |
